Cough Suppressant Drugs Market Research Report by Disease Type, Drug Type, Age Group, Dosage Form, Distribution Channel, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030- Product Image

Sale

Cough Suppressant Drugs Market Research Report by Disease Type, Drug Type, Age Group, Dosage Form, Distribution Channel, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

Report
142 Pages
January 2023
Region: United States
360iResearch™
ID: 5123248

UP TO €859EUR$895USD£758GBP OFF until Mar 31^st 2023

The United States Cough Suppressant Drugs Market size was estimated at USD 405.99 million in 2022, USD 434.54 million in 2023 and is projected to grow at a CAGR of 5.24% to reach USD 611.12 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Cough Suppressant Drugs Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Cough Suppressant Drugs Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Cough Suppressant Drugs Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Cough Suppressant Drugs Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Cough Suppressant Drugs Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Type, the market is studied across Dry Cough and Wet Cough.
Based on Drug Type, the market is studied across Benzonatate, Butamirate, Codeine, Dextromethorphan, Noscapine, and Pholcodine.
Based on Age Group, the market is studied across Adult and Pediatric.
Based on Dosage Form, the market is studied across Syrup and Tablet.
Based on Distribution Channel, the market is studied across Hospital, Online Pharmacy, and Retail Drug Store.
Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Cough Suppressant Drugs Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Cough Suppressant Drugs Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Cough Suppressant Drugs Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Cough Suppressant Drugs Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cough Suppressant Drugs Market, including Acella Pharmaceuticals, LLC, Alvizia Healthcare Private Limited, Amneal Pharmaceuticals, Inc., Athens Labs Ltd., Aurobindo Pharma Limited, Aytu BioScience, Inc., Bayer AG, GlaxoSmithKline PLC, Mayne Pharma, Inc., Pfizer Inc., Solace Biotech Ltd., Taro Pharmaceutical Industries, Tris Pharma, Inc., Vernalis PLC, and Zenes Biotech Pvt. Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Cough Suppressant Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Cough Suppressant Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Cough Suppressant Drugs Market?
4. What is the competitive strategic window for opportunities in the United States Cough Suppressant Drugs Market?
5. What are the technology trends and regulatory frameworks in the United States Cough Suppressant Drugs Market?
6. What is the market share of the leading vendors in the United States Cough Suppressant Drugs Market?
7. What modes and strategic moves are considered suitable for entering the United States Cough Suppressant Drugs Market?

Frequently Asked Questions about the U.S. Cough Suppressant Drugs Market

What is the estimated value of the U.S. Cough Suppressant Drugs Market?

The U.S. Cough Suppressant Drugs Market was estimated to be valued at $405.99 Million in 2022.

What is the growth rate of the U.S. Cough Suppressant Drugs Market?

The growth rate of the U.S. Cough Suppressant Drugs Market is 5.2%, with an estimated value of $611.12 Million by 2030.

What is the forecasted size of the U.S. Cough Suppressant Drugs Market?

The U.S. Cough Suppressant Drugs Market is estimated to be worth $611.12 Million by 2030.

Who are the key companies in the U.S. Cough Suppressant Drugs Market?

Key companies in the U.S. Cough Suppressant Drugs Market include Acella Pharmaceuticals, LLC, Alvizia Healthcare Private Limited, Amneal Pharmaceuticals, Inc., Athens Labs Ltd., Aurobindo Pharma Limited, Aytu BioScience, Inc., Bayer AG, GlaxoSmithKline PLC and Pfizer Inc..

Report Attribute	Details
No. of Pages	142
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 405.99 Million
Forecasted Market Value ( USD ) by 2030	$ 611.12 Million
Compound Annual Growth Rate	5.2%
Regions Covered	United States
No. of Companies Mentioned	15

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of chronic lung disorders in the U.S.
5.1.1.2. Surging numbers of smokers and allergic issues
5.1.2. Restraints
5.1.2.1. Changing costs of raw materials
5.1.3. Opportunities
5.1.3.1. Development of novel therapies and drugs
5.1.4. Challenges
5.1.4.1. Side impacts of cough depressant drugs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Cough Suppressant Drugs Market, by Disease Type
6.1. Introduction
6.2. Dry Cough
6.3. Wet Cough

7. Cough Suppressant Drugs Market, by Drug Type
7.1. Introduction
7.2. Benzonatate
7.3. Butamirate
7.4. Codeine
7.5. Dextromethorphan
7.6. Noscapine
7.7. Pholcodine

8. Cough Suppressant Drugs Market, by Age Group
8.1. Introduction
8.2. Adult
8.3. Pediatric

9. Cough Suppressant Drugs Market, by Dosage Form
9.1. Introduction
9.2. Syrup
9.3. Tablet

10. Cough Suppressant Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital
10.3. Online Pharmacy
10.4. Retail Drug Store

11. California Cough Suppressant Drugs Market
11.1. Introduction

12. Florida Cough Suppressant Drugs Market
12.1. Introduction

13. Illinois Cough Suppressant Drugs Market
13.1. Introduction

14. New York Cough Suppressant Drugs Market
14.1. Introduction

15. Ohio Cough Suppressant Drugs Market
15.1. Introduction

16. Pennsylvania Cough Suppressant Drugs Market
16.1. Introduction

17. Texas Cough Suppressant Drugs Market
17.1. Introduction

18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis, By Key Player
18.3. Market Share Analysis, By Key Player
18.4. Product Portfolio Analysis, By Key Player
18.5. Competitive Scenario
18.5.1. Merger & Acquisition
18.5.2. Agreement, Collaboration, & Partnership
18.5.3. New Product Launch & Enhancement
18.5.4. Investment & Funding
18.5.5. Award, Recognition, & Expansion

19. Company Usability Profiles
19.1. Acella Pharmaceuticals, LLC
19.2. Alvizia Healthcare Private Limited
19.3. Amneal Pharmaceuticals, Inc.
19.4. Athens Labs Ltd.
19.5. Aurobindo Pharma Limited
19.6. Aytu BioScience, Inc.
19.7. Bayer AG
19.8. GlaxoSmithKline PLC
19.9. Mayne Pharma, Inc.
19.10. Pfizer Inc.
19.11. Solace Biotech Ltd.
19.12. Taro Pharmaceutical Industries
19.13. Tris Pharma, Inc.
19.14. Vernalis PLC
19.15. Zenes Biotech Pvt. Ltd.

20. Appendix
20.1. Discussion Guide
20.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET DYNAMICS
FIGURE 8. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE TYPE, 2030
FIGURE 12. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
FIGURE 15. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG TYPE, 2030
FIGURE 17. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
FIGURE 24. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY AGE GROUP, 2030
FIGURE 26. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
FIGURE 29. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 30. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY DOSAGE FORM, 2030
FIGURE 31. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2030
FIGURE 36. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, 2018-2030 (USD MILLION)
FIGURE 39. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 47. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 48. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY STATE, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 41. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 42. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 45. CALIFORNIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 47. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 48. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 49. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 51. FLORIDA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 60. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. NEW YORK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 65. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 66. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 69. OHIO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 71. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 72. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. PENNSYLVANIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 77. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 78. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. TEXAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 83. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 84. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 85. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 86. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 87. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 88. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET MERGER & ACQUISITION
TABLE 89. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 90. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 91. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET INVESTMENT & FUNDING
TABLE 92. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 93. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET: LICENSE & PRICING